Jennifer McMahon is a Partner at Seroba. She graduated from UCD with an honours degree in Pharmacology in 2010. Jennifer then entered a Master’s degree programme in Biotechnology and Business to further her interest in the interface of biomedical science with commercialisation.
Having placed first in her Master’s degree in 2011, Jennifer then joined Seroba’s Investment Team as an Investment Analyst, progressing to Partner in 2022.
From 2019 to 2023, Jennifer sat on the Advisory Board for the European healthcare Businesswomen’s Association. She was a founding member of the Irish Chapter of Level 20 in 2019 and was appointed International Chair of the 13 European chapters in 2021 and subsequently appointed to the Level 20 Board of Directors in 2022.
Jennifer guest lectures on venture capital at University College Dublin, Trinity College Dublin and the Royal College of Surgeons in Ireland. She is also in high demand as a speaker at Investor/Entrepreneur life science partnering conferences across Europe.
Jennifer sits on the boards of Endotronix, Palliare and Deciphex, Shorla Pharma (Board Observer), ShiraTronics (Board Observer) and was previously on the Board of Biosensia prior to its merger with Kypha Diagnostics.
Outside of work, Jen can be found in local playgrounds chasing her two young kids with her husband or enjoying a picnic on a nice day. She loves reformer pilates, walking, cooking and eating out with friends and family.
View on LinkedIn